Acne Inversa-like Lesions Induced by a Low Dose of Sorafenib

Acne Inversa-like Lesions Induced by a Low Dose of Sorafenib

Authors

  • Javier Aubán-Pariente Department of Dermatology, Central University Hospital of Asturias, Oviedo, Spain
  • Laura Palacios-García Department of Dermatology, Central University Hospital of Asturias, Oviedo, Spain
  • Cristina Galache-Osuna Department of Dermatology, Central University Hospital of Asturias, Oviedo, Spain
  • Marc Mir-Bonafé Department of Dermatology, Central University Hospital of Asturias, Oviedo, Spain
  • Patricia Morales Del Burgo Department of Pathology, Central University Hospital of Asturias, Oviedo, Spain
  • Jorge Santos-Juanes Department of Dermatology, Central University Hospital of Asturias, Oviedo, Spain

Keywords:

acne inversa, sorafenib, cutaneous adverse reaction, dermatopathology

References

1. Pichler M, Carriere C, Mazzoleni G, Kluge R, Eisendle K. Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib. Clin Exp Dermatol. 2014;39(2):232-233. doi:10.1111/ced.12257
2. Borgia F, Saitta C, Vaccaro M, Franzè MS, Lentini M, Cannavò SP. Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment. Int J Immunopathol Pharmacol. 2017;30(3):327-331. doi:10.1177/0394632017727618

Downloads

Published

2021-03-08

Issue

2021 Vol 11, No 2 | April

Section

Letter

License

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

1.
Aubán-Pariente J, Palacios-García L, Galache-Osuna C, Mir-Bonafé M, Morales Del Burgo P, Santos-Juanes J. Acne Inversa-like Lesions Induced by a Low Dose of Sorafenib. Dermatol Pract Concept. 2021;11(2):e2021008. doi:10.5826/dpc.1102a08

Share

Crossref
Scopus
Google Scholar
Europe PMC